D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.

MLA

Christersson, C., et al. “D-Dimer and Risk of Thromboembolic and Bleeding Events in Patients with Atrial Fibrillation--Observations from the ARISTOTLE Trial.” Journal of Thrombosis and Haemostasis : JTH, vol. 12, no. 9, Sept. 2014, pp. 1401–12. EBSCOhost, https://doi.org/10.1111/jth.12638.

APA

Christersson, C., Wallentin, L., Andersson, U., Alexander, J. H., Ansell, J., De Caterina, R., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J. D., Huber, K., Husted, S., Hylek, E. M., Lopes, R. D., & Siegbahn, A. (2014). D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial. Journal of Thrombosis and Haemostasis : JTH, 12(9), 1401–1412. https://doi.org/10.1111/jth.12638

Chicago

Christersson, C, L Wallentin, U Andersson, J H Alexander, J Ansell, R De Caterina, B J Gersh, et al. 2014. “D-Dimer and Risk of Thromboembolic and Bleeding Events in Patients with Atrial Fibrillation--Observations from the ARISTOTLE Trial.” Journal of Thrombosis and Haemostasis : JTH 12 (9): 1401–12. doi:10.1111/jth.12638.